Cargando…
A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
BACKGROUND AND OBJECTIVES: Atypical hemolytic uremic syndrome (aHUS) is mostly attributed to dysregulation of the alternative complement pathway (ACP) secondary to disease-causing variants in complement components or regulatory proteins. Hereditary aHUS due to C3 disruption is rare, usually caused b...
Autores principales: | Pollack, Shirley, Eisenstein, Israel, Mory, Adi, Paperna, Tamar, Ofir, Ayala, Baris-Feldman, Hagit, Weiss, Karin, Veszeli, Nóra, Csuka, Dorottya, Shemer, Revital, Glaser, Fabian, Prohászka, Zoltán, Magen, Daniella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264753/ https://www.ncbi.nlm.nih.gov/pubmed/34248927 http://dx.doi.org/10.3389/fimmu.2021.608604 |
Ejemplares similares
-
Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
por: Rysava, Romana, et al.
Publicado: (2022) -
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome
por: Lemaire, Mathieu, et al.
Publicado: (2013) -
Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature
por: Matošević, Matija, et al.
Publicado: (2023) -
Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome
por: Trojnár, Eszter, et al.
Publicado: (2017) -
Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Csuka, Dorottya, et al.
Publicado: (2015)